{"id":"W2531760402","doi":"10.1182/blood.v106.11.229.229","title":"Bendamustine HCl (TREANDATM) Treatment Results in High Rates of Objective Response in Patients with Rituximab-Refractory and Alkylator-Refractory Indolent B-Cell Non-Hodgkin’s Lymphoma (NHL): Results from a Phase II Multicenter Single-Agent Study (SDX-105-01).","year":2005,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Public Health; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Bendamustine; Medicine; Rituximab; Internal medicine; Population; Refractory (planetary science); Gastroenterology; Salvage therapy; Progressive disease; Neutropenia; Oncology; Chemotherapy; Surgery; Lymphoma; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008239065,0.0003136075,0.0006269269,0.0001712326,0.000135839,0.000327519,0.0002327206,0.0003025592,0.0008426078],"category_scores_gemma":[0.000618985,0.0001741797,0.000313242,0.0001888956,0.0001815768,0.0002515765,0.0001022881,0.0006675505,0.0001790256],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003904814,"about_ca_system_score_gemma":0.0003199525,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008189561,"about_ca_topic_score_gemma":0.002093947,"domain_scores_codex":[0.9998288,0.00006418516,0.00001466859,0.00002978526,0.00003401103,0.00002853269],"domain_scores_gemma":[0.9997132,0.00008108672,0.00007125622,0.00001904176,0.0000209608,0.00009437458],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2270353,0.01658719,0.1505221,0.0008164476,0.002378925,0.0006212005,0.0005781373,0.003551198,0.2220931,0.0001165531,0.004841568,0.3708582],"study_design_scores_gemma":[0.09313016,0.2317727,0.6355247,0.00007999655,0.001444645,0.002621972,0.000149902,0.003237178,0.02465213,0.0001467987,0.007188442,0.00005136613],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9974895,0.001566743,0.000123237,0.00006217686,0.00001089956,0.0001044643,0.0001668765,0.0000261988,0.0004498805],"genre_scores_gemma":[0.9981323,0.0005318619,0.0002662038,0.0001262991,0.00002048502,0.0000478489,0.0005605845,0.000006632347,0.0003077931],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008426078,"threshold_uncertainty_score":0.004357278,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01771638027748258,"score_gpt":0.2854540597887837,"score_spread":0.2677376795113011,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}